There are 2789 resources available
974P - Genetic and molecular analysis of solid tumors with hyperprogressive disease after treatment with immunotherapy
Presenter: Daniel Trotier
Session: ePoster Display
975P - Impact of body mass index on the efficacy of immune checkpoint inhibitors in cancer
Presenter: Alejandro Rios Hoyo
Session: ePoster Display
976P - The 30-day mortality rate after first cycle of immunotherapy
Presenter: Osman Sutcuoglu
Session: ePoster Display
977P - Interim results of phase I dose escalation study of YBL-006: A novel anti-PD-1 monoclonal antibody in advanced solid tumors
Presenter: Keun-Wook Lee
Session: ePoster Display
875P - Definitive chemo-IMRT in locally advanced head and neck squamous cell carcinoma (LAHN-SCC): An experience with geriatric patients
Presenter: Imtiaz Ahmed
Session: ePoster Display
876P - Automatic segmentation of organs at risk in head and neck using 3D-UNets
Presenter: Swapneel Datta
Session: ePoster Display
Resources:
Abstract
877P - Comparison of dosimetric benefits in nasopharyngeal carcinoma patients among intensity-modulated radiotherapy, volumetric-modulated arc therapy and tomotherapy
Presenter: Wei Xiong
Session: ePoster Display
878P - Clinical profile and treatment outcomes of locally advanced carcinoma larynx treated with organ preservation approach: A retrospective analysis
Presenter: Afsar Fasaludeen
Session: ePoster Display
879P - Adaptive radiotherapy in head and neck cancer: A prospective dosimetric and volumetric study
Presenter: Apurva Pandey
Session: ePoster Display
880P - Systematic literature review (SLR) of randomized controlled trials in patients (pts) with newly diagnosed locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Karthik Ramakrishnan
Session: ePoster Display